Arkos Global Advisors’s Johnson & Johnson JNJ Stock Holding History

Arkos Global Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,927	Closed	-$463K	–	138
2024 Q1	$463K	Buy	+2,927	New	+$466K	0.08%	73
2023 Q3	–	Sell	-1,243	Closed	-$206K	–	104
2023 Q2	$206K	Buy	+1,243	New	+$201K	0.04%	96

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arkos Global Advisors's JNJ Position: Q2 2024 in Review

Arkos Global Advisors sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 2,927 shares — an estimated $463K sold.

Arkos Global Advisors first reported a position in JNJ in Q2 2023 and held it in 2 quarters. The position peaked at $463K in Q1 2024. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

Arkos Global Advisors reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
Arkos Global Advisors sold 2,927 Johnson & Johnson shares in Q2 2024, an estimated $463K.
Arkos Global Advisors first reported a position in Johnson & Johnson in Q2 2023 and held it in 2 quarters.
Arkos Global Advisors's Johnson & Johnson position peaked at $463K in Q1 2024.
3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Arkos Global Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.